Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe.
Damon WillemsEva-Lotta HinzpeterHessel H Van der ZeeChristopher J SayedJohn R IngramCharlotte BeaudartSilvia M A A EversMickaël J C HiligsmannPublished in: The patient (2023)
This study revealed the most important treatment characteristics for patients with hidradenitis suppurativa that can help inform joint patient-physician decision making in the management of hidradenitis suppurativa. Designing future hidradenitis suppurativa treatments according to stated preferences, namely, to offer higher levels of effectiveness and pain improvement without higher risks of adverse events, may increase patients' treatment concordance and lead to improved disease management outcomes.
Keyphrases
- hidradenitis suppurativa
- end stage renal disease
- case report
- systematic review
- ejection fraction
- primary care
- randomized controlled trial
- chronic kidney disease
- prognostic factors
- decision making
- type diabetes
- peritoneal dialysis
- pain management
- risk assessment
- single cell
- replacement therapy
- adipose tissue
- patient reported outcomes
- current status
- combination therapy
- glycemic control
- insulin resistance
- patient reported